• All Share : 51629.23
    UP 0.41%
    Top40 - (Tradeable) : 45069.02
    UP 0.45%
    Financial 15 : 14393.56
    UP 0.56%
    Industrial 25 : 67697.77
    DOWN -0.10%
    Resource 10 : 32578.11
    UP 1.76%

  • ZAR/USD : 13.9347
    DOWN -0.13%
    ZAR/GBP : 16.9845
    DOWN -0.77%
    ZAR/EUR : 15.1547
    DOWN -0.69%
    ZAR/JPY : 0.1335
    DOWN -0.82%
    ZAR/AUD : 10.5932
    DOWN -0.74%

  • Gold US$/oz : 1266
    UP 0.02%
    Platinum US$/oz : 931
    Silver US$/oz : 17.5
    Palladium US$/oz : 617
    DOWN -0.80%
    Brent Crude : 51.78
    DOWN -0.23%

  • All data is delayed by 15 min. Data supplied by Profile Data
    Hover cursor over this ticker to pause.

Mon Oct 24 01:51:25 SAST 2016

Artificial blood made in Romania, first tests encouraging

Times LIVE | 04 November, 2013 09:54
A bag of blood intended for transfusions.
Image by: Raymond Preston

With a huge shortage of human blood for transfusions, a new development in synthetic blood may help ease the pressure on blood banks, according to reports.

A team of researchers of the Babes-Bolyai University in Romania, has created a recipe for artificial blood, and the preliminary tests have proven encouraging.

The team, led by 39-year-old Professor Radu Silaghi-Dumitrescu, has been doing research to create the artificial blood for six years, says The Independent Balkan News Agency.

The blood is made of water, salt, albumin and a protein called hemerythrin, which is extracted from marine worms which makes the artificial blood stress resistant.

The lead researcher pointed out the tests on mice will continue until proven there is not toxicity at all, before any attempt to use it on human beings.

Success in trials over the next two years will lead the team to publish their results and Silaghi-Dumitrescu has confirmed that he will seek a patent on the formula, says science blog I Fucking Love Science.

According to the report, earlier this year, a Scottish laboratory was granted permission to begin human trials for synthetic blood derived from adult stem cells.


If you have an opinion you would like to share on this article, please send us an e-mail to the Times LIVE iLIVE team. In the mean time, click here to view the Times LIVE iLIVE section.